Neovasc Reducer™ featured in live case session at TCT 2014 Scientific Symposium (St. Paul's Hospital)
Neovasc Inc. announced today that its Reducer™ technology was featured in a “live case” broadcast on Sunday, September 14, 2014 at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. A Clinical update on the company's Tiara™ transcatheter mitral valve (TMVI) program was also presented. TCT is the world's largest educational meeting specializing in interventional cardiovascular medicine and is being held September 13–17, 2014 in Washington, DC.
Neovasc's Tiara transcatheter mitral valve was also featured in multiple scientific sessions at TCT and Dr. Anson Cheung, professor of Surgery and director of Cardiac Transplant at St. Paul's Hospital, Vancouver, Canada presented an update on the Tiara transcatheter mitral valve clinical program. Dr. Cheung indicated that the Tiara valve has now been successfully implanted in three patients under compassionate use.
Ken, cardiac patient